Barclays Maintains Underweight on Lineage, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 76.5%

Neg 0% Neu 0% Pos 76.5%

Barclays analyst Brendan Lynch maintains Lineage (NASDAQ:LINE) with a Underweight and raises the price target from $34 to $35.